Cargando…
A sulfur dioxide polymer prodrug showing combined effect with doxorubicin in combating subcutaneous and metastatic melanoma
Melanoma, as the most aggressive and treatment-resistant skin malignancy, is responsible for about 80% of all skin cancer mortalities. Prone to invade into the dermis and form distant metastases significantly reduce the patient survival rate. Therefore, early treatment of the melanoma in situ or tim...
Autores principales: | An, Lin, Zhang, Peng, Shen, Wei, Yi, Xuan, Yin, Weitian, Jiang, Rihua, Xiao, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658323/ https://www.ncbi.nlm.nih.gov/pubmed/33210029 http://dx.doi.org/10.1016/j.bioactmat.2020.10.027 |
Ejemplares similares
-
Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma.
por: Seymour, L. W., et al.
Publicado: (1994) -
Overview of Subcutaneous Metastatic Melanoma
por: Mozzillo, Nicola
Publicado: (2021) -
A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
por: Li, Zuojun, et al.
Publicado: (2018) -
A Polymer Prodrug Strategy
to Switch from Intravenous
to Subcutaneous Cancer Therapy for Irritant/Vesicant Drugs
por: Bordat, Alexandre, et al.
Publicado: (2022) -
Subcutaneous Angiomatoid Fibrous Histiocytoma Mimicking Metastatic Melanoma
por: Sparreboom, E., et al.
Publicado: (2012)